$1.140
-0.048 (-4.20%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TELO Prediction & Forecast by Similar Chart Analysis
Alphio's TELO stock price prediction model matches the current Telomir Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.16 (+1.85%). The 1-week path is $1.24 (+8.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Telomir Pharmaceuticals Inc Stock?
Telomir Pharmaceuticals Inc (TELO) is currently trading at $1.14, which is below its 200-day simple moving average of $1.279. The stock has a relative strength index (RSI) of 46.462, indicating it is neither overbought nor oversold. However, the company has reported consistent losses, with a net income of -$47,835,431 in Q2 2026 and a negative EPS of -0.79. The forward P/E ratio is 0, indicating no earnings expected in the near term. The stock has seen a year-to-date change of -14.93%, suggesting a downward trend. The main risk is the significant net loss reported, which could impact future performance. Overall, while there are some signs of potential recovery, the current financial performance and negative earnings trend suggest it may be prudent to hold off on buying until further positive developments occur.
TELO stock price ended at $1.14 on Friday, after losing -4.20%
Telomir Pharmaceuticals Inc (TELO) last closed at $1.14, losing -4.20%. These facts feed the 1-day and 1-week TELO price prediction above.
Forecast Drivers
Telomir Pharmaceuticals Inc (TELO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TELO, ranked by similarity.
Seasonality analysis for TELO
Historically the probability of a positive August return for TELO is 15.87%. January offers the highest probability of a positive month at 70.00%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TELO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.31 | $2.69 | $2.89 | +136.29% |
| Sep 2026 | $2.49 | $2.65 | $2.82 | +132.57% |
| Oct 2026 | $2.12 | $2.57 | $2.59 | +125.43% |
| Nov 2026 | $1.88 | $2.30 | $2.68 | +101.82% |
| Dec 2026 | $1.78 | $2.03 | $2.35 | +78.50% |
In 2026, Telomir Pharmaceuticals Inc (TELO) is projected to range from $1.78 to $2.89.
Telomir Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Telomir Pharmaceuticals Inc is projected to average $2.69, with a low of $2.31 and high of $2.89.
In Sep 2026, Telomir Pharmaceuticals Inc is projected to average $2.65, with a low of $2.49 and high of $2.82.
In Oct 2026, Telomir Pharmaceuticals Inc is projected to average $2.57, with a low of $2.12 and high of $2.59.
In Nov 2026, Telomir Pharmaceuticals Inc is projected to average $2.30, with a low of $1.88 and high of $2.68.
In Dec 2026, Telomir Pharmaceuticals Inc is projected to average $2.03, with a low of $1.78 and high of $2.35.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.